IDEXX Laboratories Does Not Need More Vet Visits, But It Needs More Tests Per Visit

IDEXX Laboratories is rated Hold, as its premium valuation already assumes strong recurring revenue and diagnostics growth.
Hosted on MSN

Idexx raises 2025 revenue outlook to $4.28B as inVue Dx placements surge and innovation momentum builds

Jonathan J. Mazelsky, CEO, highlighted, "IDEXX delivered a very strong quarter of performance as reflected in solid execution across all key drivers of our strategy." He emphasized rapid adoption of ...
Business Wire

InVue Expands to Create a Connected System for In-Store Retail Operations

CHARLOTTE, N.C.--(BUSINESS WIRE)--InVue, the leading global developer of intelligent hardware and software technology for retail, consumer electronics, and data centers, launches its most innovative ...